Sección para completar los datos relacionados con las publicaciones que sirven de base al protocolo. Refiera hasta un máximo de 10 referencias.
Referencias:
1.- Murphy DL, Goodwin FK, Bunney WE, Jr. Leukocytosis during lithium treatment. Am J Psychiatry. 1971; 127: 1559-61
2.- Skinner GR, Hartley C, Buchan A, Harper L, Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 1980; 168(2):139-48. Disponible en: https://doi.org/10.1007/bf02121762
3.- Wilson R, Fraser WD, McKillop JH, Smith J, O’Reilly DS, Thomson JA. The “in vitro” effects of lithium on the immune system. Autoimmunity 1989; 4:109-14
4.- Rapaport MH, Manji HK. The effects of lithium on ex vivo cytokine production. Biol Psychiatry 2001; 50(3):217-24. Disponible en: https://doi.org/10.1016/S0006-3223(01)01144-1.
5.- Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, et al. An imbalance in the production of IL-1b and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disorders. 2007; 9:743-53
6.- Taylor A, Harker JA, Chanthong K, Stevenson PG, Zuniga EI, Rudd CE. Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of co-receptor PD-1 to enhance CD8+ cytolytic T cell responses. Immunity. 2016; 44:274-86. Disponible en: http://dx.doi.org/10.1016/j.immuni.2016.01.018.
7.- Zhao FR, Xie YL, Liu ZZ. Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro. J Med Virol 2017; 89(11):2041-46. Disponible en: https://doi.org/10.1002/jmv.24821.
8.- Rudd CE. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Front Immunol. 2020; 11(1638). Disponible en: https://doi.org/10.3389/fimmu.2020.01638.
9.- Spuch C, López-García M, Rivera-Baltanás T, Rodrígues-Amorím D and Olivares JM. (2020) Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report. Front. Pharmacol. 11:557629. doi: 10.3389/fphar.2020.557629
10. Harrison SM, Tarpey I, Rothwell L, Kaiser P, Hiscox JA. Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture. Avian Pathol. 2007; 36(2):109-14.